We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stay Ahead of the Game With Fortive (FTV) Q1 Earnings: Wall Street's Insights on Key Metrics
Read MoreHide Full Article
Analysts on Wall Street project that Fortive (FTV - Free Report) will announce quarterly earnings of $0.85 per share in its forthcoming report, representing an increase of 2.4% year over year. Revenues are projected to reach $1.49 billion, declining 2.1% from the same quarter last year.
The consensus EPS estimate for the quarter has undergone a downward revision of 1.6% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some Fortive metrics that Wall Street analysts commonly model and monitor.
According to the collective judgment of analysts, 'Sales- Intelligent Operating Solutions' should come in at $669.35 million. The estimate indicates a change of +0.6% from the prior-year quarter.
Analysts' assessment points toward 'Sales- Advanced Healthcare Solutions' reaching $303.14 million. The estimate points to a change of +1.1% from the year-ago quarter.
The average prediction of analysts places 'Sales- Precision Technologies' at $524.46 million. The estimate points to a change of -6.2% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Adjusted Operating Profit (Non-GAAP)- Advanced Healthcare Solutions' of $74.55 million. Compared to the current estimate, the company reported $72.50 million in the same quarter of the previous year.
Analysts predict that the 'Adjusted Operating Profit (Non-GAAP)- Intelligent Operating Solutions' will reach $211.49 million. The estimate compares to the year-ago value of $211.90 million.
Analysts forecast 'Adjusted Operating Profit (Non-GAAP)- Precision Technologies' to reach $122.67 million. Compared to the present estimate, the company reported $136.50 million in the same quarter last year.
Shares of Fortive have experienced a change of -6% in the past month compared to the -0.2% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), FTV is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Stay Ahead of the Game With Fortive (FTV) Q1 Earnings: Wall Street's Insights on Key Metrics
Analysts on Wall Street project that Fortive (FTV - Free Report) will announce quarterly earnings of $0.85 per share in its forthcoming report, representing an increase of 2.4% year over year. Revenues are projected to reach $1.49 billion, declining 2.1% from the same quarter last year.
The consensus EPS estimate for the quarter has undergone a downward revision of 1.6% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some Fortive metrics that Wall Street analysts commonly model and monitor.
According to the collective judgment of analysts, 'Sales- Intelligent Operating Solutions' should come in at $669.35 million. The estimate indicates a change of +0.6% from the prior-year quarter.
Analysts' assessment points toward 'Sales- Advanced Healthcare Solutions' reaching $303.14 million. The estimate points to a change of +1.1% from the year-ago quarter.
The average prediction of analysts places 'Sales- Precision Technologies' at $524.46 million. The estimate points to a change of -6.2% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Adjusted Operating Profit (Non-GAAP)- Advanced Healthcare Solutions' of $74.55 million. Compared to the current estimate, the company reported $72.50 million in the same quarter of the previous year.
Analysts predict that the 'Adjusted Operating Profit (Non-GAAP)- Intelligent Operating Solutions' will reach $211.49 million. The estimate compares to the year-ago value of $211.90 million.
Analysts forecast 'Adjusted Operating Profit (Non-GAAP)- Precision Technologies' to reach $122.67 million. Compared to the present estimate, the company reported $136.50 million in the same quarter last year.
View all Key Company Metrics for Fortive here>>>
Shares of Fortive have experienced a change of -6% in the past month compared to the -0.2% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), FTV is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>